Bolstered by 9.5% gain over three months, Ipsos stock advances another 2.5%
The market research group rebounds in trading, supported by a rising Paris market. This recovery follows a month of decline and brings the stock back towards technical levels tracked over recent weeks.
A rebound that brings the price above the 20-day moving average
The Ipsos stock gains 2.28% to €36.76, while the SBF 120 advances 0.94%. The stock stands above its MA20 (€35.27, a 4.22% gap) and its MA200 (€35.86), but remains below its MA50 at €37.19, or 1.16% higher than the current price. The RSI at 48 is neutral and the stock remains at a distance from the support level of €34.56, which the September 30 session had threatened. Over three months, the gain reaches 9.34%, compared to 1.94% over one month.
A confirmed Horizons plan and a share buyback already well underway
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
On September 14, Chief Executive Officer Kelly Beaver confirmed the Horizons strategic plan and made accelerated execution its priority. For shareholders, the €57 million buyback programme announced on July 22 was executed at approximately 54% as of October 6, with €31 million already repurchased. According to the consensus of analysts surveyed, the stock is valued at approximately 7.1 times current fiscal year earnings and 6.5 times those of the following fiscal year. The resistance level at €39.40 is the next technical level to watch.
Dans ces conditions et malgré une hausse du carnet de commandes à la fin du premier semestre, le Groupe anticipe désormais une croissance organique autour de 2 %
Risks mentioned
Baisse des revenus due à des effets de change défavorables.
Impact négatif de la déconsolidation de la Russie.
Opportunities identified
Retour à la croissance organique positive de 0,8 % au S1.
Outlook / guidance
Expected revenue: 2 475 millions d'euros
Management commentary: le Groupe anticipe désormais une croissance organique autour de 2 %
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
